Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Iron Therapy in Fibromyalgia
NCT01820052Phase 3Completed
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Start
- Apr 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fibromyalgia (FM) comparing Oral Iron + SOC with Placebo + SOC (2 arms). Primary endpoints: Widespread Pain Index at 3 months, Symptom Severity Scale at 3 months and 1 more. Started Apr 2013; status: completed.
02
Drugs
Iron
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01820052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01820052.